and when does Phase I results get released? Looking for $1.85 as the low before we get news. Jan. will be the 1 year anniversary of Phase II starting, you would think you would get news about phase I before phase II is fully enrolled.
Don't know what you are complaining about. You will find a nice most recent phase I update for ICT-107 on the company website embedded in a worthwhile investor presentation posted Oct.'12., if you go to 'investors' and then 'webcasts&presentations'. If you look for a more 'official' release: ASCO'12 (you find the poster on the same website).
Most remarkable: The median overall survival is an astounding 38.4 months; two patients (out of 16 = 13%) are still alive with more than 3 years of documented progressive disease; 3 patients (19%) are alive without disease progression for at least 5 years after diagnosis, 6 patients (38%) progression free for 4 years and more. See yourself!
The proof will be in the randomized phase II trial that is fully recruited and on-going. A planned interim analysis is due Q1/Q2 2013, final results should mature in the second half of 2013.